Protein C and protein S deficiency in thalassemic patients

Area of Science:

• Hematology
• Coagulation Disorders

Background:

• Thalassemia is a group of inherited blood disorders characterized by reduced hemoglobin production.
• Patients with thalassemia often experience complications related to altered hemostasis and increased thrombotic risk.

Purpose of the Study:

• To evaluate the levels of protein C and protein S, key components of the anticoagulant pathway, in patients with various forms of thalassemia.
• To investigate the potential correlation between reduced protein C and protein S levels and the thrombotic complications observed in thalassemia.

Main Methods:

• Plasma levels of protein C, protein S, and other liver-produced coagulant proteins were measured in 30 adults and 18 children with beta-thalassemia/HbE disease, beta-thalassemia major, and HbE disease.
• Statistical analysis was performed to compare protein levels between thalassemic patients and potentially reference groups, and to assess the impact of splenectomy.

Main Results:

• Thalassemic patients exhibited significantly lower mean levels of protein C (50.4%) and protein S (58.8%) compared to other measured coagulant proteins.
• The reduction in protein C levels was more pronounced than that of protein S.
• Splenectomized patients demonstrated significantly lower gamma-carboxylated protein C levels compared to non-splenectomized patients.

Conclusions:

• The protein C-protein S anticoagulant pathway is impaired in thalassemic patients.
• Severe deficiencies in protein C and protein S may contribute to the heightened risk of thrombosis in this patient population.
• Further research is warranted to elucidate the precise mechanisms linking thalassemia, anticoagulant protein deficiency, and thrombosis.